A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.

@article{McDermott2006APD,
  title={A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.},
  author={Clare McDermott and Selwyn C M Richards and Peter D. Thomas and Julie Montgomery and George Lewith},
  journal={QJM : monthly journal of the Association of Physicians},
  year={2006},
  volume={99 7},
  pages={461-8}
}
BACKGROUND Previous research has suggested that natural killer (NK) cell activity may be reduced in patients with chronic fatigue syndrome (CFS). AIM To evaluate the effectiveness of a putative NK cell stimulant, BioBran MGN-3, in reducing fatigue in CFS patients. DESIGN Randomized, double-blind, placebo-controlled trial. METHODS We recruited 71 patients with CFS (according to the Centers for Disease Control 1994 criteria) attending an out-patient specialist CFS service. Participants were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomised controlled trial

  • F Brouwers, S van der Werf, G Bleijenberg
  • Q J Med
  • 2002
Highly Influential
11 Excerpts

A descriptive Questionnaire-Based Study on the use of BioBran (MGN-3) in Chronic Fatigue Syndrome

  • J. Kenyon
  • Townsend Letter for Doctors and Patients,
  • 2001
Highly Influential
12 Excerpts

Clinical improvement in chronic fatigue syndrome is associated with enhanced natural killer cell-mediated cytotoxicity: the results of a pilot study with Isoprinosine

  • F Diaz-Mitoma, E Turgonyi, A Kumar
  • J Chronic Fatigue Syndr
  • 2003
2 Excerpts

Enhancement of human natural killer cell activity by modified arabinoxylane from rice bran (MGN-3)

  • M. Ghoneum
  • Int J Immunotherapy
  • 1998
1 Excerpt

Similar Papers

Loading similar papers…